Development of an allergen extract for sublingual immunotherapy – evaluation of Staloral

Bibliography

• The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet 1998;351:1225-32
   PubMed Web of Science ®Google Scholar
• Galassi C, De Sario M, Biggeri A, et al. Changes in prevalence of asthma and allergies among children and adolescents in Italy: 1994-2002. Pediatrics 2006;117:34-42
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Szwarcberg J, Pill MW. Allergic rhinitis, asthma, and rhinosinusitis: diseases of the integrated airway. J Manag Care Pharm 2004;10:310-7
   PubMedGoogle Scholar
• Bousquet J, Lockey RF, Malling HJ, editors. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53(Suppl 44):1-42
   Web of Science ®Google Scholar
• Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437-48
   PubMed Web of Science ®Google Scholar
• Wilson DR, Torres-Lima M, Durham S. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12
   PubMed Web of Science ®Google Scholar
• Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis and asthma due to house dust mite. Clin Allergy 1986;16:483-91
   PubMedGoogle Scholar
• Norman PS. Why standardized extract? J Allergy Clin Immunol 1986;77:405-6
   PubMed Web of Science ®Google Scholar
• Platts Mills TA, Chapman MD. Allergen standardization. J Allergy Clin Immunol 1991;87:621-5
   PubMed Web of Science ®Google Scholar
• Becker WM, Vogel L, Vieths S. Standardization of allergen extracts for immunotherapy: where do we stand? Curr Opin Allergy Clin Immunol 2006;6:470-5
   PubMed Web of Science ®Google Scholar
• American Medical Association, Current Procedural Terminology (CPT) 2005 standard edition, Chicago, American Medical Association, 2005
   Google Scholar
• Passalacqua G, Villa G, Altrinetti V, et al. Sublingual swallow or spit? Allergy 2001;56:578
   PubMed Web of Science ®Google Scholar
• Marogna M, Spadolini I, Massolo A, et al. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients. Ann Allergy Asthma Immunol 2007;98:274-80
   PubMed Web of Science ®Google Scholar
• Dunsky E, Goldstein MF, Dvorin MJ, Belecanech GA. Anaphylaxis to sublingual immunotherapy. Allergy 2006;61:1235
   PubMed Web of Science ®Google Scholar
• Eifan AO, Keles S, Bahceciler NN, Barlan IB. Anaphylaxis to multiple pollen allergen sublingual immunotherapy. Allergy 2007;62:567-8
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Valovirta E, van Weissenbruch R, et al, editors, Sublingual specific immunotherapy. From scientific background to clinical practice. Milan, Sinergie: 2007
   Google Scholar
• Fiocchi A, Pajno G, La Grutta S, et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol 2005;95:254-8
   PubMed Web of Science ®Google Scholar
• Rossi R, Monasterolo RE. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma. Int J Immunopathol Pharmacol 2005;18:277-85
   PubMed Web of Science ®Google Scholar
• Tripodi S, Di Rienzo Businco A, et al. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children. Int Arch Allergy Immunol 2005;139:149-52
   PubMed Web of Science ®Google Scholar
• Ariano R, Incorvaia C, La Grutta S, et al. Safety of sublingual immunotherapy started during the pollen season. Curr Med Res Opin 2009;25:103-7
   PubMed Web of Science ®Google Scholar
• Cadario G, Ciprandi G, Di Cara G, et al. Comparison between continuous or intermittent schedules of sublingual immunotherapy for house dust mites: effects on compliance, patients satisfaction, quality of life and safety. Int J Immunopathol Pharmacol 2008;21:471-3
   PubMed Web of Science ®Google Scholar
• Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo controlled trial of a standardized five grass-pollen extract in rhinitis. Allergy 1998;53:493-8
   PubMed Web of Science ®Google Scholar
• Ott H, Sieber J, Brehler R, et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009;64:179-86
   PubMed Web of Science ®Google Scholar
• Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol 1990;10:277-84
   Google Scholar
• Bousquet J, Van Cauwenberge P, editors. Allergic rhinits and its impact on asthma (ARIA). J Allergy Clin Immunol 2001;108(Suppl 5):S146-50
   PubMed Web of Science ®Google Scholar
• Sabbah A, Hassoun S, Le Sellin J, et al. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-13
   PubMed Web of Science ®Google Scholar
• Pradalier A, Basset D, Claudel A, et al. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999;54:819-28
   PubMed Web of Science ®Google Scholar
• Vourdas D, Syrigou E, Potamianou P, et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998;53:662-72
   PubMed Web of Science ®Google Scholar
• La Rosa M, Ranno C, André C, et al. Double blind placebo controlled evaluation of sublingual swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425-32
   PubMed Web of Science ®Google Scholar
• André C, Perrin-Fayol M, Grosclaude M, et al. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Evidence for a dose-response relationship. Int Arch Allergy Immunol 2003;131:111-8
   PubMed Web of Science ®Google Scholar
• Bowen T, Greenbaum J, Charbonneau Y, et al. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis. Ann Allergy Asthma Immunol 2004;93:425-30
   PubMed Web of Science ®Google Scholar
• Khinchi MS, Poulsen LK, Carat F, et al. Clinical efficacy of sublingual and subcutaneous birch-pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004;59:45-53
   PubMed Web of Science ®Google Scholar
• Di Rienzo V, Pucci S, D'Alò S, et al. Effects of high dose sublingual immunotherapy on quality of life in patients with cypress-induced rhinitis: a placebo-controlled study. Clin Exp Allergy Rev 2006;6:67-70
   Google Scholar
• Vervloet D, Birnbaum J, Laurent P, et al. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study. Int Arch Allergy Immunol 2007;142:239-46
   PubMed Web of Science ®Google Scholar
• Lue KH, Lin YH, Sun HL, et al. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol 2006;17:408-15
   PubMed Web of Science ®Google Scholar
• Bousquet J, Scheinmann P, Guinnepain MT, et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house dust mites: a double-blind, placebo-controlled study. Allergy 1999;54:249-60
   PubMed Web of Science ®Google Scholar
• Mungan D, Misirligil Z, Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma: a placebo-controlled study. Ann Allergy Asthma Immunol 1999;82:485-90
   PubMed Web of Science ®Google Scholar
• Bahceciler NN, Isik U, Barlan IB, Basaran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001;32:49-55
   PubMed Web of Science ®Google Scholar
• Mortemousque B, Bertel F, De Casamayor J, et al. House dust mite sublingual swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy 2003;33:464-9
   PubMed Web of Science ®Google Scholar
• Tonnel AB, Scherpereel A, Douay B, et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004;59:491-7
   PubMed Web of Science ®Google Scholar
• Niu CK, Chen WY, Huang JL, et al. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo controlled study in Taiwan. Respir Med 2006;100:1374-83
   PubMed Web of Science ®Google Scholar
• Guez S, Vatrinet C, Fadel R, André C. House dust mite sublingual swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 2000;55:369-75
   PubMed Web of Science ®Google Scholar
• Pham-Thi H, Scheinmann P, Fadel R, et al. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pediatr Allergy Immunol 2007;18:47-57
   PubMed Web of Science ®Google Scholar
• Calamita Z, Saconato H, Pel AB, Atallah N. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration Method. Allergy 2006;61:1162-72
   PubMed Web of Science ®Google Scholar
• Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97(2):141-8
   PubMed Web of Science ®Google Scholar
• Penagos M, Passalacqua G, Compalati E, et al. Meta-analysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008;133:599-609
   PubMed Web of Science ®Google Scholar
• Marcucci F, Sensi L, Di cara G, et al. Dose dependence of immunological response to sublingual immunotherapy. Allergy 2005;60:952-6
   PubMed Web of Science ®Google Scholar
• Frati F, Sensi L, Di Rienzo V, et al. A model for management of sublingual immunotherapy. Eur Ann Allergy Immunol 2003;35:56-60
   PubMedGoogle Scholar
• André C, Vatrinet C, Galvain S, et al. Safety of sublingual swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:229-34
   PubMed Web of Science ®Google Scholar
• Gidaro GB, Marcucci F, Sensi L, et al. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy 2005;35:565-71
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Frati F, Puccinelli P, et al. Dose dependence of efficacy and safety of subcutaneous immunotherapy. Monaldi Arch Chest Dis 2006;65:41-3
   PubMedGoogle Scholar
• Eifan AO, Keles S, Bahceciler NN, Barlan IB. Anaphylaxis to multiple pollen allergen sublingual immunotherapy. Allergy 2007;62:567-8
   PubMed Web of Science ®Google Scholar
• Blazowski L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy 2008;63:374
   PubMed Web of Science ®Google Scholar
• Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007;119:780-91
   PubMed Web of Science ®Google Scholar
• Romagnani S. Regulation of the T cell response. Clin Exp Allergy 2006;36:187-96
   Web of Science ®Google Scholar
• Taylor A, Verhagen J, Blaser K, et al. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells. Immunology 2006;117:433-42
   PubMed Web of Science ®Google Scholar
• Bohle B, Kinaciyan T, Gerstmayr M, et al. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007;120:707-13
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Frati F. On mechanism of action of sublingual immunotherapy. Pediatr Allergy Immunol 2009;20:102
   PubMed Web of Science ®Google Scholar
• Noirey N, Rougier N, André C, et al. Langerhans-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naive T lymphocytes. J Allergy Clin Immunol 2000;105:1194-201
   PubMed Web of Science ®Google Scholar
• Marcucci F, Sensi L, Incorvaia C, et al. Oral reactions to sublingual immunotherapy: a bioptic study. Allergy 2007;62:1475-7
   PubMed Web of Science ®Google Scholar
• Marcucci F, Incorvaia C, Sensi L, et al. Lack of inflammatory cells in the oral mucosa of subjects undergoing sublingual immunotherapy. Int J Immunopathol Pharmacol 2008;21:609-13
   PubMed Web of Science ®Google Scholar
• Frati F, Moingeon P, Marcucci F, et al. Mucosal immunization application to allergic disease: sublingual immunotherapy. Allergy Asthma Proc 2007;28:35-9
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Mauro M, Ridolo E, et al. Patient's compliance with allergen immunotherapy. Patient Preference Adherence 2008;2:247-51
   PubMedGoogle Scholar
• Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 1993;91:734-7
   PubMed Web of Science ®Google Scholar
• Lower T, Henry J, Mandik L, et al. Compliance with allergen immunotherapy. Ann Allergy Asthma Immunol 1993;70:480-2
   Web of Science ®Google Scholar
• Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy. Ann Allergy Asthma Immunol 1999;82:281-6
   PubMed Web of Science ®Google Scholar
• Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004;114:851-7
   PubMed Web of Science ®Google Scholar
• Marogna M, Spadolini I, Massolo A, et al. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004;59:1205-10
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Musarra A, Pecora S, et al. Quantitative assessment of the compliance with once-daily sublingual immunotherapy regimen in real life EASY project: evaluation of a novel SLIT formulation during a year. J Allergy Clin Immunol 2006;117:946-8
   PubMed Web of Science ®Google Scholar
• Lombardi C, Gani F, Landi M, et al. Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol 2004;113:1219-20
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Musarra A, Pecora S, et al. Quantitative assessment of the compliance with once daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year). Pediatr Allergy Immunol 2007;18:56-62
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Frati F, Puccinelli P, et al. Adherence to sublingual immunotherapy: the allergist's viewpoint. Allergy (In Press)
   Google Scholar
• Berto P, Bassi M, Incorvaia C, et al. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma. Eur Ann Allergy Clin Immunol 2005;37:303-8
   PubMedGoogle Scholar
• Berto P, Passalacqua G, Crimi N, et al. Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: The Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study. Ann Allergy Asthma Immunol 2006;97:615-21
   PubMed Web of Science ®Google Scholar
• Berto P, Frati F, Incorvaia C, et al. Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study. Curr Med Res Opin 2008;24:261-6
   PubMed Web of Science ®Google Scholar
• Berto P, Frati F, Incorvaia C. Economic studies of immunotherapy: a review. Curr Opin Allergy Clin Immunol 2008;8:585-9
   PubMed Web of Science ®Google Scholar